Marchex (MCHX) CFO settles 7,500 RSUs into Class B shares

Rhea-AI Filing Summary

Marchex Inc Chief Financial Officer Brian Nagle exercised 7,500 restricted stock units into 7,500 shares of Class B Common Stock. The Form 4 shows a derivative exercise (code M) on March 20, 2026 at a stated price of $0.00 per unit.

According to the footnote, these restricted stock units were granted effective March 20, 2025 and vested in full on the first anniversary of the grant date. After the settlement, Nagle directly holds 7,500 shares of Class B Common Stock and no remaining units from this award. The filing reports no share sales or tax-withholding dispositions, indicating a routine compensation-related vesting and share issuance.

Insider Trade Summary

7,500 shares exercised/converted

Mixed 2 txns

Insider Nagle Brian

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	7,500	$0.00	--
Exercise	Class B Common Stock	7,500	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Class B Common Stock — 7,500 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nagle Brian

(Last) (First) (Middle)

1200 5TH AVE

SUITE 1300

(Street)

SEATTLE WASHINGTON 98101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARCHEX INC [ MCHX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Common Stock	03/20/2026		M		7,500	A	(1)	7,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/20/2026		M			7,500	(1)	(1)	Class B Common Stock	7,500	$0	0	D

Explanation of Responses:

1. Restricted stock units award effective March 20, 2025 (the "Grant Date"). Each restricted stock unit represents the right to receive one share of the Corporation's Class B Common Stock upon vesting, which occurs in full on the first anniversary of the Grant Date.

	/s/ Brian Nagle	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Marchex (MCHX) CFO Brian Nagle report in this Form 4?

Brian Nagle reported exercising 7,500 restricted stock units into 7,500 shares of Marchex Class B Common Stock. The transaction reflects settlement of previously granted equity compensation rather than an open-market stock purchase or sale.

Was the Marchex CFO’s 7,500-share transaction a stock sale?

No, the transaction was not a sale. The CFO exercised restricted stock units, converting them into 7,500 shares of Class B Common Stock, with no reported dispositions, open-market sales, or tax-withholding share transfers in this filing.

What were the terms of the Marchex CFO’s restricted stock unit award?

The award became effective on March 20, 2025, with each unit representing one Class B share upon vesting. The units vested in full on the first anniversary of the grant date, leading to the issuance of 7,500 shares on March 20, 2026.

How many Marchex shares does the CFO hold after this Form 4 transaction?

Following the transaction, the Form 4 reports that Brian Nagle directly holds 7,500 shares of Marchex Class B Common Stock. These shares result from the vesting and conversion of 7,500 restricted stock units from his prior equity award.

Does this Marchex Form 4 indicate any remaining derivative awards for the CFO?

The filing’s derivative position summary is empty, and the restricted stock unit line shows zero units following the transaction. This indicates the 7,500-unit award was fully settled into shares, with no remaining units from that specific grant.